What's on the horizon for the life sciences industry? Robin Johnson, PharmD, Gene Therapy Submissions Lead, inSeption Group What unique challenges do gene therapy submissions face compared to ...

Marks & Clerk says there is a lack of clarity over how IP protection safeguards the innovations underpinning the UK medtech ...

As an investor, you know that a startup’s intellectual property (IP) can be among its most valuable assets. A strong IP ...

The incoming Trump administration is expected to make several policy changes likely to impact tech transactions. President-elect Donald Trump ...